rubeola (measles) virus vaccine, inactivated, Morten strain
Trade name: Rubeovax
Vaccineapproved
Approved
Apr 1, 1968
Clinical trial activity
0 trials · 0 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Timeline
1960s
- Apr 1, 1968
Earliest FDA Approval
Indications
Approved for
Mechanism of action
- Measles virusImmunity, active
Measles virus immunity, active
Approval history
- approvedApr 1, 1968
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No